Announcements Trials
Browse Landscape

Phase

Phase 2 18Phase 3 5Phase 4 1Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 2Colonic Neoplasms 2Stomach Neoplasms 1Rectal Neoplasms 1Peripheral Nervous System Diseases 1Neoplasm Metastasis 1

Interventions

Fluorouracil 5Oxaliplatin 4Surgical Procedures, Operative 3Radiotherapy 3Neoadjuvant Therapy 3Leucovorin 3Drug Therapy 3Chemoradiotherapy 3Capecitabine 3Irinotecan 2Immune Checkpoint Inhibitors 2Folfox protocol 2Bevacizumab 2sulindac sulfone 1sintilimab 1XELOX 1Water 1Surveys and Questionnaires 1Preoperative Exercise 1Photochemotherapy 1N-dihydrogalactochitosan 1Microwaves 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Leucine-tRNA Ligase 1Injections 1Indocyanine Green 1In Situ Hybridization, Fluorescence 1Immunohistochemistry 1HMPL-013 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Rectal Neoplasms × XELOX × Clear all
NCT03957733 2022-04-06

Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.

King Abdullah Medical City

Phase 2/3 Unknown
338 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡